Thermo Fisher Scientific (TMO) Share-based Compensation (2009 - 2026)

Thermo Fisher Scientific has reported Share-based Compensation for 18 years, with the latest figure at $82.0 million in Q2 2026.

• Share-based Compensation for Q2 2026 came in at $82.0 million, up 1.23% year-over-year; the trailing twelve-month figure through Jun 2026 was $319.0 million (up 5.28% YoY), and the FY2025 annual result was $310.0 million, up 2.99% from the prior year.
• Share-based Compensation fell to $82.0 million in Q2 2026, from $83.0 million in the prior quarter.
• Over five years, Share-based Compensation peaked at $84.0 million in Q2 2024 and troughed at $61.0 million in Q4 2023.
• A 5-year average of $75.6 million and a median of $76.5 million in 2022 frame the typical range for Share-based Compensation.
• The widest annual swing landed in 2022, when Share-based Compensation surged 52.94%; it then declined 18.67% in 2023.
• A 5-year view of Share-based Compensation shows it stood at $75.0 million in 2022, then declined by 18.67% to $61.0 million in 2023, then grew by 29.51% to $79.0 million in 2024, then increased by 6.33% to $84.0 million in 2025, then declined by 2.38% to $82.0 million in 2026.
• Per Business Quant data, the three most recent Share-based Compensation figures were $82.0 million in Q2 2026, $83.0 million in Q1 2026, and $84.0 million in Q4 2025.